Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum

Hepatology

Volumn 63, Issue 4, 2016, Pages 1287-1298

  Abu Hayyeh, Shadi ^a   Ovadia, Caroline ^a   Lieu, Tinamarie ^b   Jensen, Dane D ^b   Chambers, Jenny ^a,c   Dixon, Peter H ^a,c   Lövgren Sandblom, Anita ^d   Bolier, Ruth ^e   Tolenaars, Dagmar ^e   Kremer, Andreas E ^e,f   Syngelaki, Argyro ^g   Noori, Muna ^c   Williams, David ^h   Marin, Jose J G ⁱ   Monte, Maria J ⁱ   Nicolaides, Kypros H ^g   Beuers, Ulrich ^e   Oude Elferink, Ronald ^e   Seed, Paul T ^a   Chappell, Lucy ^a   Marschall, Hanns Ulrich ^j   Bunnett, Nigel W ^b,k   Williamson, Catherine ^a,c   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

ⁱ UNIVERSITY OF SALAMANCA   (Spain)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; BILE ACID; BIOLOGICAL MARKER; PROGESTERONE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; INTRAHEPATIC CHOLESTASIS; LOW RISK PATIENT; MALE; METABOLITE; MOUSE; MOUSE STRAIN; NONHUMAN; OBSTETRIC PROCEDURE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; STILLBIRTH; ANIMAL; ANIMAL BEHAVIOR; BLOOD; BREEDING; CASE CONTROL STUDY; CHOLESTASIS, INTRAHEPATIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; ODDS RATIO; PREDICTIVE VALUE; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; UNITED KINGDOM;

ADULT; ANIMALS; BEHAVIOR, ANIMAL; BILE ACIDS AND SALTS; CASE-CONTROL STUDIES; CHOLESTASIS, INTRAHEPATIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, ANIMAL; PROGESTERONE; PRURITUS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; UNITED KINGDOM;

EID: 84952836650     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28265     Document Type: Article

References (26)

1. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014;124:120-133.
2. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467-474.
3. Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 2014;59:1482-1491.
4. Kenyon AP, Tribe RM, Nelson-Piercy C, Girling JC, Williamson C, Seed PT, et al. Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet Med 2010;3:25-29.
5. Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 1999;4:35-37.
6. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008;47:376-379.
7. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010;139:1008-1018.
8. Kremer AE, Bolier R, Dixon PH, Geenes V, Chambers J, Tolenaars D, et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol 2015;62:897-904.
9. Alemi F, Kwon E, Poole DP, Lieu T, Lyo V, Cattaruzza F, et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 2013;123:1513-1530.
10. Heikkinen J, Maentausta O, Ylostalo P, Janne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gynecol Reprod Biol 1982;14:153-162.
11. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008;47:544-551.
12. Abu-Hayyeh S, Papacleovoulou G, Lovgren-Sandblom A, Tahir M, Oduwole O, Jamaludin NA, et al. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 2013;57:716-726.
13. +-taurocholate co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites. J Biol Chem 2010;285:16504-16512.
14. Vallejo M, Briz O, Serrano MA, Monte MJ, Marin JJ. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J Hepatol 2006;44:1150-1157.
15. Meng LJ, Reyes H, Palma J, Hernandez I, Ribalta J, Sjovall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol 1997;27:346-357.
16. Geenes V, Lovgren-Sandblom A, Benthin L, Lawrance D, Chambers J, Gurung V, et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS One 2014;9:e83828.
17. Moser K, Stanfield KM, Leon DA. Birthweight and gestational age by ethnic group, England and Wales 2005: introducing new data on births. Health Stat Q 2008;(39):22-55.
18. Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012;92:497-501.
19. Jiang LI, Collins J, Davis R, Lin KM, DeCamp D, Roach T, et al. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J Biol Chem 2007;282:10576-10584.
20. Jensen DD, Godfrey CB, Niklas C, Canals M, Kocan M, Poole DP, et al. The bile acid receptor TGR5 does not interact with beta-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J Biol Chem 2013;288:22942-22960.
21. Poole DP, Godfrey C, Cattaruzza F, Cottrell GS, Kirkland JG, Pelayo JC, et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil 2010;22:814-818.
22. Sjovall J, Sjovall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann Clin Res 1970;2:321-337.
23. Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000;32:94-106.
24. Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012;344:e3799.
25. Keitel V, Spomer L, Marin JJ, Williamson C, Geenes V, Kubitz R, et al. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term. Placenta 2013;34:810-816.
26. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484-489.